Company Data
Viridian Therapeutics Inc.
Ticker
VRDN
Current Price
$30.905 -1.73%
Market Cap
$2.9B
Price Target
Refer to Report
Volume
155.3K
52wk Range
$9.9 - $32.54
Overview
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.